Nadolol compared to propranolol for treating chronic stable angina pectoris

Area of Science:

• Cardiology
• Pharmacology

Background:

• Stable angina pectoris is a common condition requiring effective treatment.
• Beta-blockers like propranolol and nadolol are frequently used to manage angina.
• Understanding the comparative efficacy and dosing of different beta-blockers is crucial for clinical practice.

Purpose of the Study:

• To determine the relative efficacy and dose equivalency of propranolol (four times daily) and nadolol (once daily) in treating stable angina pectoris.
• To compare the effectiveness of these two beta-blockers on exercise capacity and angina frequency.

Main Methods:

• A double-blind, randomized, placebo-controlled crossover study involving ten patients with stable angina pectoris.
• Doses of propranolol and nadolol were titrated to achieve equivalent heart rate reduction during exercise.
• Evaluated treadmill exercise time to ST-segment depression and weekly angina attack frequency.

Main Results:

• Both propranolol and nadolol significantly increased exercise time to ST-segment depression compared to placebo (p<0.05 and p<0.01, respectively).
• The mean frequency of angina attacks decreased from eight per week on placebo to three per week on both propranolol and nadolol (p<0.05).
• The average dose ratio was 1.17:1 (propranolol to nadolol), with identical effective doses in 60% of patients.

Conclusions:

• Propranolol and nadolol demonstrate comparable efficacy in treating stable angina pectoris.
• While generally similar, individual dose titration is advised when switching between propranolol and nadolol due to observed dosage variability in some patients.